An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.
about
Pre-eclampsia part 1: current understanding of its pathophysiology.Increased protein-coding mutations in the mitochondrial genome of African American women with preeclampsia.Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia.In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae.Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practiceOn the pitfalls of adjusting for gestational age at birth.Placental Features of Late-Onset Adverse Pregnancy Outcome.Inflammatory and Angiogenic Factors at Mid-Pregnancy Are Associated with Spontaneous Preterm Birth in a Cohort of Tanzanian Women.The "Great Obstetrical Syndromes" are associated with disorders of deep placentationMaternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD).Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies.Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state.The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.Placental growth factor concentration in maternal circulation decreases after fetal death: lessons from a case series study.Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.Third trimester fetal demise occurring at time of delivery: correlation of autopsy findings and placental pathology with emphasis on antenatal central nervous system injury.Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal side of placenta of women with preeclampsia.Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).Biochemical markers of placental dysfunction in assisted conception.The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.Bone Marrow-Derived Endothelial Progenitor Cells Reduce Recurrent Miscarriage in Gestation.Do the physiological aging of the placenta and the changes in angiogenesis marker sFlt-1 and PlGF concentrations predispose patients to late-onset preeclampsia?Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
P2860
Q33416340-9E9A1E8C-43F9-45D9-933A-7533FBC917D9Q33714774-F213464B-A594-4C08-B00A-3A0E15B11CA1Q33863973-0F7D9390-66C0-4A3C-B29A-ED0F315C2C18Q34119241-052E713B-DE2E-446E-BCEB-9413DCCC8CE5Q34505704-CAE04079-3154-454D-B36F-F90BF4CD1A84Q34619975-81C9DD63-F8F0-47E4-9143-A2D1084B792EQ34975562-A75F5D44-2D22-49D1-B8F0-5C0BC639C2D4Q35204444-AF712D6F-77DE-475A-BE24-93BD2D4254FBQ35627448-8DFD713D-7F6B-4893-91E6-53565054E6A1Q35676928-DCF57CC7-14A5-4A40-8CEB-4A8ECDD0FBDFQ35738529-7F098A28-E5FB-4CA8-A050-7BAF2FFF5638Q36015615-E2667EC2-139C-4DFC-B3E7-4EB6FB97F65FQ36062460-D27145F7-5EB0-41E9-928B-F7A8E88C3CBAQ36421501-A3C4F144-9AB9-406B-8D40-9CE694206835Q36455584-EC1BDCBB-79A5-429D-8E6F-AE6C925B1F4FQ36538942-6249D790-398D-4DA3-88CB-0E2AF17CC644Q37612429-9C6A8B24-BF27-4970-B00C-671919996DD0Q37723245-792BC2AB-F37C-4B65-A3D3-CADC2BBA1964Q38436237-331E84C7-9642-4179-8284-D603BB454D65Q38458497-8723D836-4F74-4B29-835B-355D0799D2D5Q39376655-3EDAEBCE-12FA-423E-8988-21E92B62385EQ41033848-B86378B1-11AC-415B-9EFA-36A4EE096E82Q44236033-EA47BBD6-A0EC-4C97-A813-88489B28FD11Q44314054-83254FC3-3771-45E8-861D-8BD951B634C5Q47162116-C4D4457C-9729-47DD-AD0C-698A3F59251DQ47645647-A7DF9FDD-A474-465C-AF0F-7F79698187E4Q48717665-FE4BA95A-23AD-4F66-AA03-C0B7C69C2099Q49312791-5A223ADA-6C5A-4848-9D0C-33598776659FQ51577960-54D4CEB8-A51F-40EB-A47C-EAE0BE922568Q51802500-04D6DE0F-48B2-49CD-B7BD-ABDB874FBBBDQ54406971-0B7B2455-62E4-4561-81EE-08DDD1A7FD61
P2860
An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An imbalance between angiogeni ...... sults of a longitudinal study.
@ast
An imbalance between angiogeni ...... sults of a longitudinal study.
@en
An imbalance between angiogeni ...... sults of a longitudinal study.
@nl
type
label
An imbalance between angiogeni ...... sults of a longitudinal study.
@ast
An imbalance between angiogeni ...... sults of a longitudinal study.
@en
An imbalance between angiogeni ...... sults of a longitudinal study.
@nl
prefLabel
An imbalance between angiogeni ...... sults of a longitudinal study.
@ast
An imbalance between angiogeni ...... sults of a longitudinal study.
@en
An imbalance between angiogeni ...... sults of a longitudinal study.
@nl
P2093
P2860
P50
P1476
An imbalance between angiogeni ...... sults of a longitudinal study.
@en
P2093
Adi L Tarca
Giovanna Ogge
Juan Pedro Kusanovic
Maria Teresa Gervasi
Offer Erez
Pooja Mittal
Shali Mazaki-Tovi
Sonia S Hassan
Sun Kwon Kim
P2860
P304
P356
10.3109/14767051003681121
P577
2010-05-12T00:00:00Z